Protalix Biotherapeutics plans $60 million US bond offering

–   The Gaucher and plant-cell treatment developer is offering a convertible note to US financial institutions. –   -/ By Nadav Neuman / Protalix Biotherapeutics Inc. (NYSE:PLX; TASE: PLX) More...